English press releases

HSBC SFH (France): Update on the Sale of HSBC Continental Europe’s Retail Banking Business in France

PARIS–(BUSINESS WIRE)– Regulatory News: HSBC SFH (France) (Paris:HSBAK): NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO...

Rimini Consult™ Demand and Accolades Continue to Grow as Services for Oracle, SAP, Salesforce, Databases and Other Enterprise Software Successfully Enable and Accelerate Innovation for Clients

Increasing number of Rimini Street clients benefit from its proven, unique professional services model, more experienced talent and on-time delivery of better outcomes LAS VEGAS–(BUSINESS...

Apple Retains Crown as World’s Most Valuable Brand in Kantar BrandZ Ranking

Microsoft overtakes Amazon to join Google in the top three McDonald’s is the most valuable non-tech brand; Coca-Cola rejoins the Top 10 LONDON–(BUSINESS WIRE)– Apple...

Logitech Announces CEO Departure

Board Member Guy Gecht Appointed Interim CEO; Bracken Darrell to Depart Logitech LAUSANNE, Switzerland & NEWARK, Calif.–(BUSINESS WIRE)– SIX Swiss Exchange Ad hoc announcement pursuant...

Mars Completes Acquisition of Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions

Heska becomes part of Mars Petcare’s Science & Diagnostics division to broaden access to diagnostics and technology, accelerate R&D and innovation, and better serve more...

ESUPS Makes Humanitarian Relief More Efficient With Help From Gurobi

The humanitarian project launched a platform that optimizes the allocation of relief items. BEAVERTON, Ore.–(BUSINESS WIRE)– Gurobi Optimization, LLC, the leader in decision intelligence technology,...

Seagen Announces ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 98% Overall Response Rate and 93% Complete Response Rate in Patients with Early-Stage Classical Hodgkin Lymphoma (cHL)

– Updated phase 2 data results presented for ADCETRIS in combination with immune therapy nivolumab and doxorubicin and dacarbazine chemotherapy – – Regimen well-tolerated with...

Thales Helps Lunit Accelerate the Growth of AI-based Software Cancer Diagnostic Solutions

Back-office software automation helps increase operational efficiency and improve customer satisfaction Protection of intellectual property and core technology instrumental in Lunit’s global expansion PARIS LA...

J.P. Morgan Launches Sustainable Investment Data Solutions for Institutional Investors

NEW YORK–(BUSINESS WIRE)– J.P. Morgan Securities Services announced today the launch of its Sustainable Investment Data Solutions for institutional investors, available through Fusion by J.P....

SES Announces its Chief Executive Officer Steve Collar to Step Down

LUXEMBOURG–(BUSINESS WIRE)– SES announces today that Steve Collar, Chief Executive Officer (CEO), will be stepping down at the end of June 2023 to pursue other...

Vertex Presents Data Demonstrating Significant Benefits of Long-Term Treatment With CFTR Modulators at the European Cystic Fibrosis Conference

-Interim results of largest real-world study of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) showed sustained improvement in lung function, reduction in pulmonary exacerbations frequency and lower rates...

Mega Refining and Petrochemical Plant Selects Hytera as Provider of Professional Communications System

SHENZHEN, China–(BUSINESS WIRE)– Hytera, a global leading provider of professional communication technologies and solutions, has been selected as the supplier of professional communications solution for...

Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress

– Both trials met the primary and key secondary endpoints at the pre-specified interim analysis – – Data continue to demonstrate transformative and durable benefit...

FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

– First CRISPR gene-editing filings to be accepted for review by FDA – – FDA grants Priority Review for severe sickle cell disease (SCD) and...

Verisign Reports Internet Has 354.0 Million Domain Name Registrations at the End of the First Quarter of 2023

RESTON, Va.–(BUSINESS WIRE)– VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that the first quarter of...